What are the diagnostic criteria and initial treatment approach for a patient presenting with symptoms of depression according to the DSM-5 TR (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DSM-5 TR Diagnostic Criteria for Major Depressive Disorder

Major Depressive Disorder requires at least 5 out of 9 symptoms present during the same 2-week period, with at least one symptom being either depressed mood or loss of interest/pleasure (anhedonia), causing clinically significant distress or functional impairment. 1, 2

Core Diagnostic Criteria

The DSM-5 TR requires the following for diagnosis:

  • At least 5 symptoms from a list of 9 must be present during the same 2-week period and represent a change from previous functioning 1, 2
  • At least one symptom must be either:
    • Depressed mood most of the day, nearly every day 1, 3
    • Markedly diminished interest or pleasure in all or almost all activities (anhedonia) 1, 3

The Nine DSM-5 Symptoms

  1. Depressed mood most of the day, nearly every day 1, 2
  2. Anhedonia - markedly diminished interest or pleasure in activities 1, 2
  3. Weight/appetite changes - significant weight loss or gain (>5% body weight in a month), or decrease/increase in appetite 1
  4. Sleep disturbance - insomnia or hypersomnia nearly every day 1, 2
  5. Psychomotor changes - agitation or retardation observable by others 1, 2
  6. Fatigue or loss of energy nearly every day 1, 2
  7. Feelings of worthlessness or excessive/inappropriate guilt 1, 2
  8. Diminished ability to think or concentrate, or indecisiveness 1, 2
  9. Recurrent thoughts of death, suicidal ideation, suicide attempt, or specific plan 1, 2

Critical Diagnostic Requirements

  • Functional impairment must be present - symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning 1, 2
  • Not attributable to substances or medical conditions - the episode is not due to physiological effects of a substance or another medical condition 1
  • Not better explained by other disorders - the episode is not better explained by schizoaffective disorder, schizophrenia, or other psychotic disorders 1

Severity Classification Based on DSM-5 Criteria

Mild depression: 5-6 symptoms that are mild in intensity with minimal functional impairment 1, 2

Moderate depression: Symptom count, intensity, and impairment fall between mild and severe categories 1, 2

Severe depression: All or most of the 9 symptoms present with severe functional impairment, OR presence of any of the following high-risk features automatically classifies as severe regardless of symptom count 1, 2:

  • Specific suicide plan, clear intent, or recent attempt 1, 2
  • Psychotic symptoms 1, 2
  • First-degree family history of bipolar disorder 1
  • Marked functional impairment 1, 2

Bereavement Consideration (DSM-5 TR vs DSM-5 Difference)

  • The diagnostic threshold should be raised during bereavement - depressive symptoms consistent with normative grief responses within the individual's cultural/religious context should not be diagnosed as depression 4
  • Depression during bereavement is suggested by: persistence of symptoms for at least one month AND presence of extreme beliefs of worthlessness/guilt unrelated to the deceased, psychotic symptoms, suicidal ideation, or psychomotor retardation 4

Initial Treatment Approach

Severity-Based Treatment Algorithm

For mild depression (5-6 symptoms, minimal impairment):

  • Initiate cognitive behavioral therapy (CBT) alone as first-line treatment - antidepressants should NOT be used for mild depression as drug-placebo differences are virtually nonexistent in this population 5

For moderate to severe depression:

  • Initiate either CBT or a second-generation antidepressant (SSRI or SNRI) as first-line treatment, with choice guided by patient preference and adverse effect profiles 5
  • Quantify baseline severity using PHQ-9 (scores 1-7 minimal, 8-14 moderate, ≥15 severe) or Hamilton Depression Rating Scale before initiating treatment 5, 2

Treatment Monitoring Protocol

  • Assess response within 1-2 weeks of treatment initiation, monitoring for therapeutic effects, adverse effects, and emergence of suicidality 5
  • Evaluate for adequate response by 6-8 weeks - if inadequate improvement, modify treatment through dose adjustment, switching agents, or adding augmentation strategies 5
  • Minimum trial duration is 4-6 weeks for antidepressants before considering treatment failure 5

Critical Pitfalls to Avoid

  • Do not diagnose depression based solely on symptom count - always assess all three dimensions: symptom count, intensity, AND functional impairment, as these are only moderately correlated 2, 3
  • Do not prescribe antidepressants for mild depression - this represents inappropriate treatment with no demonstrated benefit 5
  • Do not omit PHQ-9 item 9 (thoughts of self-harm) as this artificially lowers scores and may miss critical suicide risk 2
  • Always rule out bipolar disorder - presence of first-degree family history of bipolar disorder or antidepressant-induced hypomania/mania requires mood stabilizers, not antidepressants alone 1, 6
  • Do not count medication discontinuation due to side effects before 4 weeks as treatment failure when considering treatment-resistant depression 6

Symptom Pattern Recognition for Clinical Decision-Making

  • Depressed mood + somatic symptoms (sleep, appetite, fatigue, psychomotor changes) suggests moderate depression with potential autonomic dysfunction and higher cardiovascular risk 3
  • Anhedonia + non-somatic symptoms (worthlessness, guilt, concentration problems, suicidal thoughts) indicates severe depression with higher suicide risk requiring immediate intervention 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Depression Severity Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment Approach for Depression Unspecified

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment-Resistant Depression: Evidence-Based Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) criteria for major depressive disorder?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing other specified depressive disorder?
What are the possible DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) codes for a 63-year-old male patient with severe major depressive disorder (MDD), anxiety, insomnia, diabetes, and hypertension?
What are the changes in the diagnosis of Bipolar I disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) (Diagnostic and Statistical Manual of Mental Disorders) versions 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) (International Classification of Diseases) versions 10 and 11?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing substance/medication-induced depressive disorder?
What is the recommended treatment for a patient with a history of a category 3 bite, previously treated with intramuscular (IM) rabies vaccine and rabies immunoglobulin (RIG), who completed the first 4 doses of the post-exposure prophylaxis (PEP) series but missed the 5th dose on day 28?
What is the best course of treatment for a patient, possibly an older adult with a history of stroke or dementia, experiencing difficulty swallowing (dysphagia) pills and food?
What is the appropriate treatment for a patient with onychomycosis in the left fifth toe, considering potential underlying conditions such as diabetes or a compromised immune system?
Why is Fosamax (alendronate) not routinely prescribed for postmenopausal women with a history of osteoporosis?
What is the recommended dosing of sertraline (selective serotonin reuptake inhibitor (SSRI)) for a peri- or postmenopausal woman experiencing hot flashes?
What is the best course of treatment for a patient presenting with a sore throat, nausea, vomiting, and mild tenderness to the right lower abdomen?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.